These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study. Gisbert JP, Cruzado AI, Garcia-Gravalos R, Pajares JM. Hepatogastroenterology; 2004; 51(55):303-8. PubMed ID: 15011890 [Abstract] [Full Text] [Related]
6. Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study. Kupcinskas L, Lafolie P, Lignell A, Kiudelis G, Jonaitis L, Adamonis K, Andersen LP, Wadström T. Phytomedicine; 2008 Jun; 15(6-7):391-9. PubMed ID: 18467083 [Abstract] [Full Text] [Related]
7. [The effectiveness of ranitidine in non-ulcer dyspepsia (functional dyspepsia) in comparison with an antacid]. Hotz J, Plein K, Bunke R. Med Klin (Munich); 1994 Feb 15; 89(2):73-80, 107. PubMed ID: 8164599 [Abstract] [Full Text] [Related]
8. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. Peura DA, Kovacs TO, Metz DC, Siepman N, Pilmer BL, Talley NJ. Am J Med; 2004 Jun 01; 116(11):740-8. PubMed ID: 15144910 [Abstract] [Full Text] [Related]
9. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study. Veldhuyzen van Zanten SJ, Chiba N, Armstrong D, Barkun A, Thomson A, Smyth S, Escobedo S, Lee J, Sinclair P. Am J Gastroenterol; 2005 Jul 01; 100(7):1477-88. PubMed ID: 15984968 [Abstract] [Full Text] [Related]
15. Epigastric pain in dyspepsia and reflux disease. Vakil N. Rev Gastroenterol Disord; 2003 Aug 01; 3 Suppl 4():S16-21. PubMed ID: 14671510 [Abstract] [Full Text] [Related]
16. [The effect of Helicobacter pylori eradication on chronic use of acid-suppressant medication by patients in general practice; a randomised, double-blind study]. Hurenkamp GJ, Grundmeijer HG, van der Ende A, Tytgat GN, Assendelft WJ, van der Hulst RW. Ned Tijdschr Geneeskd; 2004 Nov 27; 148(48):2390-6. PubMed ID: 15615275 [Abstract] [Full Text] [Related]
17. Tegaserod in patients with mechanical sensitivity and overlapping symptoms of functional heartburn and functional dyspepsia. Miner PB, Rodriguez-Stanley S, Proskin HM, Kianifard F, Bottoli I. Curr Med Res Opin; 2008 Aug 27; 24(8):2159-72. PubMed ID: 18561877 [Abstract] [Full Text] [Related]
18. Effects of itopride hydrochloride and ranitidine in patients with functional dyspepsia: comparison between prokinetic and acid suppression therapies. Chiba T, Tokunaga Y, Ikeda K, Takagi R, Chishima R, Terui T, Kudara N, Endo M, Inomata M, Orii S, Suzuki K. Hepatogastroenterology; 2007 Sep 27; 54(78):1878-81. PubMed ID: 18019739 [Abstract] [Full Text] [Related]
19. Comparing the efficacy of cisapride and ranitidine in oesophagitis: a double-blind, parallel group study in general practice. Dakkak M, Jones BP, Scott MG, Tooley PJ, Bennett JR. Br J Clin Pract; 1994 Sep 27; 48(1):10-4. PubMed ID: 8179973 [Abstract] [Full Text] [Related]
20. [Functional dyspepsia, gastric emptying of solids, and Helicobacter pylori infection]. Monés Xiol J, Sainz Sáenz-Torre S, Carrió Gasset I, Berná Roqueta L, Sancho Poch FJ, Vilardell Viñas F. Rev Esp Enferm Dig; 1994 May 27; 85(5):325-30. PubMed ID: 8049101 [Abstract] [Full Text] [Related] Page: [Next] [New Search]